← FDA Drug Approvals (Drugs@FDA)
SUCRALFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2024-05-21
Drug application
- FDA Application #
ANDA216474- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUCRALFATE
- Generic name
- SUCRALFATE
- Active ingredients
- SUCRALFATE
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- STRIDES PHARMA
- Manufacturer
- Strides Pharma Science Limited
- First approval
- 2024-05-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown